Cerity Partners
LLY icon

Cerity Partners’s Eli Lilly LLY Stock Holding History

Cerity Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$276K Buy
+300
New +$304K ﹤0.01% 2671

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Cerity Partners's LLY Position: Q1 2026 in Review

Cerity Partners increased its Eli Lilly (LLY) stake by 3.4% in Q1 2026, buying an estimated $24.7M and bringing the position to 732,549 shares worth $674M. The position accounts for 0.95% of the portfolio, ranked #17.

Cerity Partners first reported a position in LLY in Q1 2017 and has held it in 37 quarters since. The position peaked at $761M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cerity Partners held 732,549 shares of Eli Lilly worth $674M as of Q1 2026.
  • Cerity Partners bought 24,369 Eli Lilly shares in Q1 2026, an estimated $24.7M.
  • Eli Lilly made up 0.95% of Cerity Partners's portfolio in Q1 2026, its #17 holding.
  • Cerity Partners first reported a position in Eli Lilly in Q1 2017 and has held it in 37 quarters since.
  • Cerity Partners's Eli Lilly position peaked at $761M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.